Table III.
Complication or other outcome | Obese with MetS, % | Obese without MetS, % | p-value |
---|---|---|---|
Length of stay, days | 3.3 | 3.2 | < 0.0001* |
Discharge home | 61.03 | 68.35 | < 0.0001† |
Central nervous system | 0.07 | 0.08 | 0.8346† |
Cardiac | 0.72 | 0.55 | < 0.0001† |
Deep vein thrombosis | 0.34 | 0.34 | 0.9913† |
Gastrointestinal | 0.26 | 0.22 | 0.0163† |
Genitourinary | 0.57 | 0.41 | < 0.0001† |
Haematoma/seroma | 0.55 | 0.54 | 0.6762† |
Postoperative infection | 0.15 | 0.15 | 0.9265† |
Pulmonary embolism | 0.4 | 0.45 | 0.3785† |
Postoperative anaemia | 24.67 | 21.38 | < 0.0001† |
Peripheral vascular disease | 0.10 | 0.11 | 0.6005† |
Respiratory | 0.13 | 0.14 | 0.6673† |
Wound dehiscence | 0.11 | 0.10% | 0.3623 |
Independent-samples t-test.
Chi-squared test.
MetS, metabolic syndrome.